Biomaterials play an important role in clinical trials and clinical applications, driving advancements in healthcare and regenerative applications. This chapter offers a comprehensive overview of biomaterials, their classification, characteristics, and attributes in various fields which includes tissue engineering, biomedical and clinical drug delivery systems. It explores the challenges and prospects in biomaterial research, including biocompatibility, immunological responses, regulatory considerations, and patient safety. The chapter also discusses the integration of biomaterials with digital health technologies, personalized medicine approaches, and emerging trends in the field. Furthermore, it highlights the importance of regulatory compliance, ethical considerations, and long-term monitoring in the approval and regulation of biomaterials. Future directions for research and applications are outlined, including advanced biomaterials, personalized medicine, biofabrication techniques, and the integration of biomaterials with nanotechnology and digital health. The chapter concludes by summarizing the findings and implications of biomaterials in clinical trials and clinical applications, emphasizing their potential to transform healthcare and improve patient outcomes.